Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bharat Biotech Covaxin likely to get WHO emergency use nod by October 5

Ruchika Sharma20 Sept 2021 11:18 AM IST

New Delhi: World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the...

Mylab buys majority stake in POC testing system developers Sanskritech

Ruchika Sharma20 Sept 2021 11:00 AM IST

Pune: Mylab Discovery Solutions, has announced acquisition of majority stake in Sanskritech , the developer of Swayam for an undisclosed amount. The...

Erbitux, adagrasib combination shrinks tumors in 39 percent of colon cancer patients: Mirati Therapeutics

Ruchika Sharma20 Sept 2021 10:15 AM IST

New Delhi: A combination of Mirati Therapeutics Inc's genetic mutation-targeting adagrasib and older cancer drug Erbitux shrank tumors in 39% of...

Zydus Cadila gets USFDA nod for depression drug Vortioxetine

Ruchika Sharma19 Sept 2021 11:00 AM IST

Ahmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the United States Food and Drug...

Pfizer COVID booster doses only for people 65 and older: USFDA advisers

Ruchika Sharma19 Sept 2021 10:30 AM IST

Washington: The US Food and Drug Administration advisory (FDA) committee on Friday (local time) voted unanimously to authorize Pfizer booster shots...

Camurus CAM2029 to treat polycystic liver disease granted orphan drug status by USFDA

Ruchika Sharma19 Sept 2021 10:00 AM IST

Sweden: Camurus has recently announced that the US Food and Drug Administration (USFDA) has granted orphan drug designation (ODD) for the company's...

Health Canada approves Moderna NDS for Spikevax to prevent COVID in 12 years, older

Ruchika Sharma19 Sept 2021 9:15 AM IST

Cambridge: Moderna has recently announced that Health Canada has approved the New Drug Submission (NDS-CV) for SPIKEVAX (elasomeran mRNA...

Indian pharma ecosystem an example for others to follow, says Colombian envoy

Ruchika Sharma19 Sept 2021 9:00 AM IST

New Delhi: Ahead of the high-level delegation meeting between India and Colombia, the envoy of Colombia on Friday praised the Indian pharmaceutical...

Reduced GST rates on COVID drugs extended till December

Ruchika Sharma18 Sept 2021 5:44 PM IST

Lucknow: The GST Council on Friday extended concessional tax rates on COVID-19 medicines, cut tax on cancer drugs and waived GST on import of highly...

Bharat Biotech awaits WHO feedback for Covaxin emergency use listing

Ruchika Sharma18 Sept 2021 12:54 PM IST

New Delhi: Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its...

COVID vaccine protection wanes, makes case for booster, says Moderna

Ruchika Sharma18 Sept 2021 11:03 AM IST

Chicago: New data from Moderna Inc's large Covid-19 vaccine trial shows that the protection it offers declines over time, supporting the case for...

Takeda Pharma gets USFDA nod for cancer treatment EXKIVITY

Ruchika Sharma18 Sept 2021 10:00 AM IST

Osaka: Drugmaker, Takeda Pharmaceutical Company Limited, has recently announced that the U.S. Food and Drug Administration (USFDA) has...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok